DENVER, March 12, 2026–Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II clinical trial (RCT), offering an early signal that could reshape how advanced pancreatic cancer is treated. Conducted in partnership with USC Norris Comprehensive Cancer Center, Mayo Clinic, HonorHealth Research Institute, and others, the study was peer-reviewed and published in Cancer, revealing that Virta’s medically supervised, individualized nutriti
Virta Health’s Nutrition Therapy Extends Survival by 34% in Stage IV Pancreatic Cancer Patients, New Clinical Trial Shows
Latest from Blog
Risk Of Death, Major Disease High Following Type 2 Diabetes Diagnosis
Post Content Post Views: 1
Trump uses ‘contested’ power to cut more funding to HHS
Hello and good morning! I hope everyone stayed dry and got some good binge watching in. Speaking of which, The New York Times has finally released its full ranking of the top
1 In 5 Seniors At Risk For Dangerous Drug Interactions MedNews
MONDAY, Sept. 28, 2026 More than 1 in 5 seniors are at risk for a potentially dangerous drug interaction from the medications they ve been prescribed, a new stu Post Views: 1
Exercise A Solid Prescription For Pain, Review Reports
Post Content Post Views: 1
Eliminating Ultra-Processed Food From School Cafeterias Will Be Costly, Complicated, Study Warns
Post Content Post Views: 1